PL446345A1 - Zestaw do określania metodą łańcuchowej reakcji polimerazy układu alleli w locus rs143334143 oraz rs74956615 - Google Patents

Zestaw do określania metodą łańcuchowej reakcji polimerazy układu alleli w locus rs143334143 oraz rs74956615

Info

Publication number
PL446345A1
PL446345A1 PL446345A PL44634523A PL446345A1 PL 446345 A1 PL446345 A1 PL 446345A1 PL 446345 A PL446345 A PL 446345A PL 44634523 A PL44634523 A PL 44634523A PL 446345 A1 PL446345 A1 PL 446345A1
Authority
PL
Poland
Prior art keywords
determining
locus
chain reaction
polymerase chain
allele system
Prior art date
Application number
PL446345A
Other languages
English (en)
Other versions
PL249351B1 (pl
Inventor
Eugeniusz Stanisław Krawczyk
Original Assignee
Biolab Genetic Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolab Genetic Spółka Z Ograniczoną Odpowiedzialnością filed Critical Biolab Genetic Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL446345A priority Critical patent/PL249351B1/pl
Publication of PL446345A1 publication Critical patent/PL446345A1/pl
Priority to PCT/PL2024/050074 priority patent/WO2025080150A1/en
Publication of PL249351B1 publication Critical patent/PL249351B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest zestaw do badania obecności dwóch polimorfizmów genetycznych, których występowanie istotnie modyfikuje przebieg choroby COVID-19, oraz sposób określenia poziomu ryzyka ciężkiego przebiegu COVID-19 u pacjenta.
PL446345A 2023-10-10 2023-10-10 Zestaw i sposób do określania metodą łańcuchowej reakcji polimerazy układu alleli w locus rs143334143 oraz rs74956615 PL249351B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL446345A PL249351B1 (pl) 2023-10-10 2023-10-10 Zestaw i sposób do określania metodą łańcuchowej reakcji polimerazy układu alleli w locus rs143334143 oraz rs74956615
PCT/PL2024/050074 WO2025080150A1 (en) 2023-10-10 2024-10-10 Kit and method for determining by polymerase chain reaction the allele configuration at the rs143334143 locus and at the rs74956615 locus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL446345A PL249351B1 (pl) 2023-10-10 2023-10-10 Zestaw i sposób do określania metodą łańcuchowej reakcji polimerazy układu alleli w locus rs143334143 oraz rs74956615

Publications (2)

Publication Number Publication Date
PL446345A1 true PL446345A1 (pl) 2024-06-17
PL249351B1 PL249351B1 (pl) 2026-03-30

Family

ID=91539530

Family Applications (1)

Application Number Title Priority Date Filing Date
PL446345A PL249351B1 (pl) 2023-10-10 2023-10-10 Zestaw i sposób do określania metodą łańcuchowej reakcji polimerazy układu alleli w locus rs143334143 oraz rs74956615

Country Status (2)

Country Link
PL (1) PL249351B1 (pl)
WO (1) WO2025080150A1 (pl)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022120130A1 (en) * 2020-12-03 2022-06-09 Regeneron Pharmaceuticals, Inc. Methods of identifying subjects having an increased risk of developing a coronavirus infection and treatment thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4158067A4 (en) * 2020-05-27 2024-09-25 Genetic Technologies Limited Methods of assessing risk of developing a severe response to coronavirus infection

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022120130A1 (en) * 2020-12-03 2022-06-09 Regeneron Pharmaceuticals, Inc. Methods of identifying subjects having an increased risk of developing a coronavirus infection and treatment thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FERREIRA, L.C. I IN.: "Infection, Genetics and Evolution 106 (2022) 105379", "GENOME-WIDE ASSOCIATION STUDIES OF COVID-19: CONNECTING THE DOTS" *
PAIRO-CASTINEIRA, E. I IN.: "Nature (2021): 591(7848): 92-98", "GENETIC MECHANISMS OF CRITICAL ILLNESS IN COVID-19" *

Also Published As

Publication number Publication date
PL249351B1 (pl) 2026-03-30
WO2025080150A1 (en) 2025-04-17

Similar Documents

Publication Publication Date Title
Renauer et al. Identification of susceptibility loci in IL6, RPS9/LILRB3, and an intergenic locus on chromosome 21q22 in Takayasu arteritis in a genome‐wide association study
Hanson et al. Genetic Variants in ERAP 1 and ERAP 2 Associated With Immune‐Mediated Diseases Influence Protein Expression and the Isoform Profile
Alikian et al. Next-generation sequencing-assisted DNA-based digital PCR for a personalized approach to the detection and quantification of residual disease in chronic myeloid leukemia patients
Blanco et al. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers
Grinfeld et al. A common novel splice variant of SLC 22 A 1 (OCT 1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia
De Rooy et al. A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis
Smith et al. The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis
Fonseca et al. Endothelin axis polymorphisms in patients with scleroderma
Misra et al. Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians
JP7523817B2 (ja) 移植拒絶リスクを予測する新規の方法
Ruiz et al. Genetic testing in hereditary breast and ovarian cancer using massive parallel sequencing
Rezaiezadeh et al. The association of ACE I/D polymorphism with the severity of COVID-19 in Iranian patients: A case-control study
Saboia et al. DLX1 and MMP3 contribute to oral clefts with and without positive family history of cancer
Sata et al. Quantitative polymerase chain reaction analysis with allele-specific oligonucleotide primers for individual IgH VDJ regions to evaluate tumor burden in myeloma patients
Gronlund et al. Droplet digital PCR for sensitive relapse detection in acute myeloid leukaemia patients transplanted by reduced intensity conditioning
PL446345A1 (pl) Zestaw do określania metodą łańcuchowej reakcji polimerazy układu alleli w locus rs143334143 oraz rs74956615
Hans et al. Characterization of MHC class II B polymorphism in multiple populations of wild gorillas using non‐invasive samples and next‐generation sequencing
Writzl et al. Copy number of DAZ genes in infertile men
Van der Veer et al. Multilocus sequence typing of Trichomonas vaginalis clinical samples from Amsterdam, the Netherlands
JP2016525876A (ja) 関節リウマチを有する患者における抗ＴＮＦαを用いた治療に対する応答の予想
Nathalang et al. Risk estimation of HNA-3 incompatibility and alloimmunization in Thai populations
Dabisch-Ruthe et al. Variants in genes encoding pyrophosphate metabolizing enzymes are associated with Pseudoxanthoma elasticum
Matter et al. HLA-G and HLA-E Gene polymorphisms in idiopathic recurrent spontaneous abortion women in Gaza strip-Palestine
Shabir et al. Nucleotide sequencing and DNA polymorphism studies of BMP 15 gene in Corriedale and local Kashmir valley sheep (Ovis aries)
Francès et al. Amelogenin test: From forensics to quality control in clinical and biochemical genomics